CASTELLI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 45.039
AS - Asia 24.758
EU - Europa 20.784
SA - Sud America 5.001
Continente sconosciuto - Info sul continente non disponibili 1.194
AF - Africa 710
OC - Oceania 51
Totale 97.537
Nazione #
US - Stati Uniti d'America 44.030
SG - Singapore 8.839
CN - Cina 8.030
UA - Ucraina 5.138
IT - Italia 4.204
BR - Brasile 4.188
HK - Hong Kong 3.003
DE - Germania 2.709
FI - Finlandia 1.587
VN - Vietnam 1.461
PL - Polonia 1.459
FR - Francia 1.325
GB - Regno Unito 1.193
TR - Turchia 993
RU - Federazione Russa 920
IE - Irlanda 885
IN - India 675
BD - Bangladesh 558
CA - Canada 508
SE - Svezia 419
AR - Argentina 298
MX - Messico 269
NL - Olanda 195
IQ - Iraq 185
ZA - Sudafrica 181
AT - Austria 168
ID - Indonesia 152
ES - Italia 147
EC - Ecuador 134
JP - Giappone 122
PK - Pakistan 118
CO - Colombia 99
SA - Arabia Saudita 92
BE - Belgio 81
BF - Burkina Faso 72
MA - Marocco 72
UZ - Uzbekistan 72
VE - Venezuela 71
JM - Giamaica 62
PY - Paraguay 62
CZ - Repubblica Ceca 58
CL - Cile 55
MU - Mauritius 54
NG - Nigeria 54
LT - Lituania 53
EG - Egitto 47
AU - Australia 45
KE - Kenya 45
JO - Giordania 44
CR - Costa Rica 41
EU - Europa 38
IR - Iran 38
CH - Svizzera 37
PH - Filippine 36
UY - Uruguay 36
AE - Emirati Arabi Uniti 35
AZ - Azerbaigian 33
ET - Etiopia 32
IL - Israele 32
TN - Tunisia 32
PE - Perù 31
GH - Ghana 30
MY - Malesia 29
HN - Honduras 27
PT - Portogallo 26
NP - Nepal 24
DZ - Algeria 23
AL - Albania 21
RO - Romania 19
BO - Bolivia 18
KZ - Kazakistan 18
OM - Oman 18
TH - Thailandia 18
TT - Trinidad e Tobago 17
LB - Libano 16
KR - Corea 15
PA - Panama 15
DO - Repubblica Dominicana 14
RS - Serbia 14
HR - Croazia 13
NI - Nicaragua 12
BG - Bulgaria 11
BH - Bahrain 11
CM - Camerun 11
GR - Grecia 11
KG - Kirghizistan 11
LK - Sri Lanka 11
BY - Bielorussia 10
PR - Porto Rico 10
SK - Slovacchia (Repubblica Slovacca) 10
BB - Barbados 9
CI - Costa d'Avorio 9
MD - Moldavia 9
PS - Palestinian Territory 9
GT - Guatemala 8
HU - Ungheria 8
KH - Cambogia 8
LV - Lettonia 8
AM - Armenia 7
BA - Bosnia-Erzegovina 7
Totale 96.217
Città #
Singapore 4.733
Jacksonville 3.642
Ashburn 3.636
Fairfield 3.589
Hong Kong 2.989
Woodbridge 2.881
Chandler 2.142
Wilmington 2.005
Houston 1.790
San Jose 1.670
Princeton 1.601
The Dalles 1.537
Beijing 1.471
Cambridge 1.470
Ann Arbor 1.463
Seattle 1.459
Warsaw 1.436
Nanjing 1.235
New York 1.136
Council Bluffs 985
Dublin 872
Helsinki 842
Los Angeles 835
Lauterbourg 800
Istanbul 785
Columbus 757
Ho Chi Minh City 488
Munich 443
Buffalo 438
Nanchang 426
Brescia 421
Milan 419
Des Moines 412
São Paulo 378
Dallas 364
Moscow 319
Shenyang 316
Changsha 295
Hanoi 284
Hebei 264
Chicago 257
Santa Clara 245
San Diego 238
Tianjin 236
Jinan 210
Dearborn 202
Shanghai 202
Jiaxing 197
Redondo Beach 195
San Francisco 193
Orem 188
London 162
Nuremberg 159
Hangzhou 151
Rome 149
Kunming 144
Rio de Janeiro 141
Toronto 139
Verona 127
Montreal 126
Boardman 120
Frankfurt am Main 117
Turku 116
Brooklyn 115
Tokyo 112
Mexico City 111
Phoenix 102
Chennai 96
Denver 96
Kocaeli 94
Atlanta 88
Johannesburg 88
Zhengzhou 88
Guangzhou 86
Belo Horizonte 83
Mcallen 83
Brasília 78
Brussels 78
Ningbo 78
Boston 76
Manchester 73
Stockholm 71
Vienna 71
Lanzhou 69
Tashkent 68
Lancaster 67
Ouagadougou 67
Baghdad 66
Haiphong 66
Salt Lake City 64
Washington 62
Jakarta 61
Romola 61
Curitiba 59
Poplar 59
Amsterdam 58
Dong Ket 58
Norwalk 56
Da Nang 55
Mumbai 55
Totale 59.860
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 494
Influence of maternal CD4+ levels on the predictive value of virus load mother-to-child transmission of HIV type 1 (HIV-1) 419
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses 380
The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia 298
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 296
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study 279
Proceedings of the IV Congress of the University Network for Development Cooperation (CUCS) “Rinforzare il capitale umano nei paesi a risorse limitate: health and wealth for all by the year 2030” 260
Cos’è la Medicina Tropicale 253
Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data 250
Effectiveness of routine lumbar puncture in patients with HIV-associated Dementia (HAD) receiving suppressive antiretroviral treatment 247
Arboviral and other illnesses in travellers returning from Brazil, june 2013 to may 2016: Implications for the 2016 olympic and paralympic games 245
Miscarriage following dengue virus 3 infection in the first six weeks of pregnancy of a dengue virus-naive traveller returning from Bali to Italy, April 2016 242
Impact of the SARS Coronavirus 2 epidemic on tuberculosis treatment outcome, Northern Italy 235
Burden of Non-AIDS-Defining and Non-Virus-Related Cancers Among HIV-Infected Patients in the Combined Antiretroviral Therapy Era. 228
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 227
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 222
Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy 221
The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: Results from the Italian MASTER Cohort 216
Hcverso1 and 2: Faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection 209
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 208
Towards tuberculosis elimination: An action framework for low-incidence countries 207
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 206
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 206
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 206
Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy 205
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy 203
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 203
Clinical and Immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa 202
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 202
A case of melioidosis probably acquired by inhalation of dusts during a helicopter flight in a healthy traveler returning from singapore 200
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial 193
Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study 192
Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV 189
A first update on mapping the human genetic architecture of COVID-19 186
Imported malaria in an HIV-positive traveler. A case-report with a fatal outcome 184
Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients 184
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 184
Malaria chemoprophylactic recommendations for immigrants to Europe, visiting relatives and friends - a Delphi method study 181
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 180
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 179
Risk of congenital toxoplasmosis in women with low or indeterminate anti-Toxoplasma IgG avidity index in the first trimester of pregnancy: an observational retrospective study 179
Mapping the human genetic architecture of COVID-19 178
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012 177
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study) 177
CD11b expression identifies CD8(+)CD28(+) T lymphocytes with phenotype and function of both naive/memory and effector cells 176
Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis 175
Active tuberculosis case finding among pregnant women: A pilot project in Burkina Faso 175
Non-typhoidal Salmonella aortitis 175
ABDOMINAL AORTITIS AND ANEURYSM IMPENDING RUPTURE DURING PNEUMOCOCCAL MENINGITIS 174
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART 173
Louse-borne relapsing fever in a refugee from Mali 173
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 173
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 172
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting 171
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy 170
Breast cancer among human immunodeficiency virus (HIV)-infected patients: the experience in Brescia, Northern Italy. 170
Comparison between the gold standard DXA with calcaneal quantitative ultrasound based-strategy (QUS) to detect osteoporosis in an HIV infected cohort 169
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study 169
Accidental and transfusion malaria in Italy 168
Consequences of the COVID-19 pandemic on the continuum of care in a cohort of people living with HIV followed in a single center of Northern Italy 168
Lung cancer in HIV-infected patients: the experience in Brescia from 1999 to 2009 167
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy 167
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 167
Advances in the treatment of malaria 166
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 166
An explainable model of host genetic interactions linked to COVID-19 severity 165
Epidemiology of malaria in endemic areas 165
Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature 165
Differential diagnosis of illness in travelers arriving from sierra Leone, Liberia, or guinea: A cross-sectional study from the Geosentinel surveillance network 164
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 164
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients 164
Migration Medicine: the Challenge of Tuberculosis 163
Coinfezione HIV/HBV in Burkina Faso, Africa Occidentalele 162
A COPD case-finding program in a large cohort of HIV-infected persons 162
Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea 161
Il panorama internazionale dell’epidemia : il rischio di AIDS nel Viaggiatore Internazionale 161
HYALURONIC ACID AND LIVER STIFFNESS REDUCTION IN HIV-HEPATITIS-C (HCV) COINFECTED PATIENTS TREATED WITH A CCR5 INHIBITOR MARAVIROC (MVC) IN A RANDOMIZED CONTROLLED TRIAL (MAICOL STUDY-48-WEEK ANALYSIS) 161
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 161
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: A MASTER cohort study 161
Key Questions in antiretroviral therapy: Italian Consensus Workshop (2005) 160
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 160
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 159
Access to antiretroviral therapy and disease progression in HIV+ migrants in Brescia, Italy 158
A Case of Rickettsia felis Infection Imported from Nepal 158
Imported malaria in northern italy: Epidemiology and clinical features observed over 18 years in the teaching hospital of Brescia 158
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 158
Long-Term Response in Patients Receiving Haart Including Nelfinavir: Experience from Two Italian Centers 157
The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population 157
Correction to: Acute epididymo-orchitis due to Salmonella Typhi in a young man from Bangladesh. 157
Caratteri generali dei protozoi patogeni per l’uomo e delle infezioni protozoarie umane 156
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy 156
Depressive disorders and personality variables in HIV positive and negative intravenous drug-users 156
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study 156
The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study 156
A Strange Manifestation of Malaria in a Native Nigerian Boy 156
Filariasis in travelers presenting to the Geosentinel Surveillance Network 155
Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C 155
Simultaneous Diagnosis of Acute Crohn's Disease and Endometriosis in a Patient Affects HIV 155
Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of northern Italy,1999-2009 152
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 151
Totale 19.181
Categoria #
all - tutte 511.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 511.933


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.533 0 1.165 114 395 89 327 250 459 330 693 506 1.205
2022/20236.001 918 106 104 597 541 1.597 18 623 927 50 232 288
2023/20245.249 378 176 396 331 222 926 176 205 1.326 69 108 936
2024/202514.206 121 74 132 1.544 1.695 1.230 1.297 596 1.556 1.247 2.930 1.784
2025/202628.010 2.578 3.709 2.113 4.285 2.602 1.844 4.075 1.139 1.825 2.253 995 592
2026/20272.719 1.529 1.190 0 0 0 0 0 0 0 0 0 0
Totale 97.537